MacroGenics - Articles and news items

MacroGenics and Merck to study margetuximab and pembrolizumb in gastric cancer

Industry news / 22 October 2015 / Victoria White

Trial startup activities are underway and MacroGenics expects to begin enrolling patients by the first quarter of 2016…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+